sugammadex teva 100 mg/ml inj. opl. i.v. flac.
teva b.v. - sugammadexnatrium 108,8 mg/ml - eq. sugammadex 100 mg/ml - oplossing voor injectie - 100 mg/ml - sugammadexnatrium 108.8 mg/ml - sugammadex
sugammadex teva 100 mg/ml inj. opl. i.v. flac.
teva b.v. - sugammadexnatrium 108,8 mg/ml - eq. sugammadex 100 mg/ml - oplossing voor injectie - 100 mg/ml - sugammadexnatrium 108.8 mg/ml - sugammadex
sugammadex sandoz 100 mg/ml inj. opl. i.v. flac.
sandoz sa-nv - sugammadexnatrium 108,8 mg/ml - eq. sugammadex 100 mg/ml - oplossing voor injectie - 100 mg/ml - sugammadexnatrium 108.8 mg/ml - sugammadex
sugammadex sandoz 100 mg/ml inj. opl. i.v. flac.
sandoz sa-nv - sugammadexnatrium 108,8 mg/ml - eq. sugammadex 100 mg/ml - oplossing voor injectie - 100 mg/ml - sugammadexnatrium 108.8 mg/ml - sugammadex
sugammadex reddy 100 mg/ml inj. opl. i.v. flac.
reddy holding gmbh - sugammadexnatrium 108,8 mg/ml - eq. sugammadex 100 mg/ml - oplossing voor injectie - 100 mg/ml - sugammadexnatrium 108.8 mg/ml - sugammadex
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromusculaire blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex teva 100 mg/ml, oplossing voor injectie
sugammadex natrium 108,8 mg/ml samenstelling overeenkomend met ; sugammadex 100 mg/ml - oplossing voor injectie - natriumhydroxide (e 524) ; stikstof (head space) (e 941) ; water voor injectie ; zoutzuur (e 507)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.